Alpha Tau Medical (DRTSW) Operating Expenses (2021 - 2026)
Alpha Tau Medical (DRTSW) posted Operating Expenses of $13.1 million for Q1 2026, up 7.59% sequentially from $12.1 million in Q4 2025, and up 47.72% YoY from $8.8 million in Q1 2025.
Alpha Tau Medical (DRTSW) Operating Expenses (2021 - 2026) Analysis & Trends
Alpha Tau Medical has reported Operating Expenses for 6 years, with the latest figure at $13.1 million in Q1 2026.
- Quarterly Operating Expenses rose 47.72% year-over-year to $13.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $44.7 million (up 28.86% YoY) and the FY2025 annual result came in at -$5.0 million, down 3.02% from the prior year.
- Operating Expenses climbed to $13.1 million in Q1 2026 per DRTSW's latest filing, from $12.1 million in the prior quarter.
- Over five years, Operating Expenses peaked at $13.1 million in Q1 2026 and troughed at $7.1 million in Q3 2022.
- A 5-year average of $8.9 million and a median of $8.5 million in 2024 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2022 and 2024: Operating Expenses surged 233.84% in 2022, then decreased 7.31% in 2024.
- Over 5 years, Operating Expenses stood at $7.6 million in 2022, then grew by 25.08% to $9.5 million in 2023, then grew by 1.01% to $9.6 million in 2024, then grew by 26.73% to $12.1 million in 2025, then gained by 7.59% to $13.1 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $13.1 million, $12.1 million, and $10.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn | 1.06 Bn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | -784.57 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 427.03 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 541.02 Mn |
| 10 | Alpha Tau Medical | 362.22 Mn | 179.81 Mn | - | 13.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.47 Mn |
| Mar 31, 2026 | 13.07 Mn |
| Dec 31, 2025 | 12.15 Mn |
| Sep 30, 2025 | 10.24 Mn |
| Jun 30, 2025 | 9.19 Mn |
| Mar 31, 2025 | 8.85 Mn |
| Dec 31, 2024 | 9.59 Mn |
| Sep 30, 2024 | 7.76 Mn |
| Jun 30, 2024 | 8.45 Mn |
| Mar 31, 2024 | 7.89 Mn |
| Dec 31, 2023 | 9.49 Mn |
| Sep 30, 2023 | 8.37 Mn |
| Jun 30, 2023 | 7.65 Mn |
| Mar 31, 2023 | 8.24 Mn |
| Dec 31, 2022 | 7.59 Mn |
| Sep 30, 2022 | 7.11 Mn |
| Jun 30, 2022 | 7.89 Mn |
| Mar 31, 2022 | 8.57 Mn |
| Dec 31, 2021 | 3.82 Mn |
| Sep 30, 2021 | 3.53 Mn |